H1043 - 2020 COVID-19 Recovery Act. (SL 2020-4)

Overview: Sec. 4.11 of S.L. 2020-4 directs the Department of Mental Health, Developmental Disabilities, and Substance Abuse Services (DMH/DD/SAS) to use $400,000 allocated in sub-subdivision (36)c. of Section 3.3 of this act to purchase units of opioid antagonist at no charge to opioid treatment programs. Sec. 4.11 requires opioid treatment programs within two weeks of receiving the opioid antagonist to provide a prescription, at least one unit of opioid antagonist, and the opportunity to obtain prescription refills for opioid antagonist to participants who meet certain criteria.

This section became effective May 4, 2020.